German federal and state health ministries agreed that from Wednesday AstraZeneca’s COVID-19 vaccine can be used for people aged 60 and above, following further reports of a rare brain blood disorder, a document on their agreement showed.
— Lees op www.reuters.com/article/us-health-coronavirus-astrazeneca-berlin-idUSKBN2BM13E
